About this item:

245 Views | 416 Downloads

Author Notes:

Correspond with: PF Sullivan (pfsulliv@med.unc.edu), Department of Genetics, CB#7264, University of North Carolina, Chapel Hill, NC, 27599-7264, USA. Voice, +919-966-3358. NR Wray (naomi.wray@uq.edu.au), Institute for Molecular Bioscience, Queensland Brain Institute, Brisbane, Australia. Voice, +61 7 334 66374.

See publication for full list of authors.

See publication for full list of author contributions.

See publication for full list of acknowledgements.

Aartjan TF Beekman: Speakers bureaus of Lundbeck and GlaxoSmithKline.

Greg Crawford: Co-founder of Element Genomics.

Enrico Domenici: Employee of Hoffmann-La Roche at the time this study was conducted, consultant to Roche and Pierre-Fabre.

Nicholas Eriksson: Employed by 23andMe, Inc. and owns stock in 23andMe, Inc.

David Hinds: Employee of and own stock options in 23andMe, Inc.

Sara Paciga: Employee of Pfizer, Inc. Craig L Hyde: Employee of Pfizer, Inc.

Ashley R Winslow: Former employee and stockholder of Pfizer, Inc.

Jorge A Quiroz: Employee of Hoffmann-La Roche at the time this study was conducted.

Hreinn Stefansson: Employee of deCODE Genetics/AMGEN.

Kari Stefansson: Employee of deCODE Genetics/AMGEN.

Stacy Steinberg: Employee of deCODE Genetics/AMGEN.

Patrick F Sullivan: Scientific advisory board for Pfizer Inc and an advisory committee for Lundbeck.

Thorgeir E Thorgeirsson: Employee of deCODE Genetics/AMGEN.

Chao Tian: Employee of and own stock options in 23andMe, Inc.

Subject:

Research Funding:

See publication for full funding statement.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Genetics & Heredity
  • LD SCORE REGRESSION
  • BODY-MASS INDEX
  • MENDELIAN RANDOMIZATION
  • EDUCATIONAL-ATTAINMENT
  • SYSTEMATIC ANALYSIS
  • MENTAL-DISORDERS
  • POLYGENIC RISK
  • EUROPE 2010
  • LOCI
  • METAANALYSIS

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

Journal Title:

Nature Genetics

Volume:

Volume 50, Number 5

Publisher:

, Pages 668-+

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic risk factors for major depression. These findings help refine the basis of major depression and imply that a continuous measure of risk underlies the clinical phenotype.

Copyright information:

© 2018 The Author(s).

Export to EndNote